Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients [21]

Lancet

Volumn 348, Issue 9040, 1996, Pages 1523-1524

  Kelly, S L ^a   Lamb, D C ^a   Kelley, D E ^a   Loeffler, J ^a   Einsele, H ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; ANTIFUNGAL AGENT; ERGOSTEROL; FLUCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; CROSS RESISTANCE; DRUG BINDING; FEMALE; HUMAN; LETTER; LONG TERM CARE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL;

EID: 0029818929     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)65949-1     Document Type: Letter

References (4)

1. DW Denning Can we prevent azole resistance in fungi? Lancer 346 1995 454
2. K Venkateswarlu DW Denning NJ Manning Resistance to fluconazole in Candida albicans from AIDS patients associated with decreased accumulation of drug FEMS Lett 131 1995 337
3. D Sanglard K Kuchler F Ischer Mechanisms of azole resistance to azole antifungal agents in Candida albicatis isolates from AIDS patients involve specific multidrug transporters Antimicrob Ag Chemother 39 1995 2378
4. SL Kelly DC Lamb AJ Corran Mode of action and resistance to azole antifungals is associated with the formation of 14α-methylergosta-8,24(28)-dien-3β,6α -diol Biochem Biophys Res Commun 207 1995 910